News for AbbVie Inc. (ABBV.MX)

Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.

AbbVie Inc. (NYSE:ABBV) Goldman Sachs 46th Annual Global Healthcare Conference June 10, 2025 11:20 AM ETCompany ParticipantsJeffrey Ryan Stewart - Executive...

AbbVie's stock outperforms the S&P 500 with a notable 7% gain year-to-date. Analyst consensus predicts a potential upside of 11.50% for AbbVie's stock.

Market Analysis by covering: S&P 500, Allergan PLC, Sherwin-Williams Co, PPG Industries Inc. Read 's Market Analysis on Investing.com

NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. (: ABBV). S

A surge of bullish sentiment is evident in AbbVie (ABBV) as options trading activity intensifies. A total of 10,792 call options have been traded, surpassing ex

Summary AbbVie Inc (ABBV) has announced the launch of its second annual AbbVie Migraine Career Catalyst Awardâ„¢ contest, which is now open for entries as of Ju

AbbVie Inc.

Summary On May 30, 2025, AbbVie Inc (ABBV) announced a multi-year partnership with the Chicago Cubs to launch the "Striking Out Cancer" campaign. This initiativ

AbbVie (ABBV) has joined forces with the Chicago Cubs in a long-term collaboration aimed at raising cancer awareness. The initiative, named ”œStriking Out Canc

Berkshire Hathaway, AbbVie and Intuitive Surgical beat estimates as analysts highlight growth drivers, headwinds and strategic moves in new reports.

NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. (: ABBV). Sh

PR NewswireNEW YORK, May 29, 2025 NEW YORK, May 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeu

AbbVie Inc.

Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all persons or entities that: (1) sol

RS Investments, an investment management company, released its “RS Large Cap Value Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, the strategy underperformed its benchmark, the Russell 1000 Value Index (the “Index”), and returned 1.57% (net) versus a return of 2.14% for the Index. […]

AbbVie Inc.

AbbVie Inc. (NYSE:ABBV) has achieved a significant legal victory as the Illinois Appellate Court upheld the dismissal of a shareholder class action lawsuit stemming from its $63 billion acquisition of Allergan plc in 2020. The lawsuit, led by plaintiff Stephen Twigg on behalf of former U.S.-based Allergan shareholders, accused ABBV of improperly issuing unregistered shares […]